Shouyan Xiang

Dr. Shouyan Xiang

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
SXShouyan Xiang
Shouyan Xiang
YLYubei Li
Yubei Li
Shah Nawaz KhanShah Nawaz Khan
Shah Nawaz Khan
WZWeixin Zhang
Weixin Zhang
GYGaoyang Yuan
Gaoyang Yuan
JCJiahua Cui
Jiahua Cui
Cancer remains a primary cause of mortality, with over 18.1 million new cases and 9.6 million deaths globally in 2018. Chemotherapy, which utilizes a spectrum of cytotoxic drugs targeting the rapidly dividing cancer cells, is a predominant treatment modality. However, the tendency of chemotherapeutics to induce drug resistance and exhibit non-specific cytotoxicity necessitates the development of new anticancer agents with heightened efficacy and minimized toxicity. In recent years, the discovery of safe and effective antibacterial/antiviral agents has also been a hot spot in medicinal chemistry. This paper comprehensively reviews the synthesis, anticancer/antibacterial/antiviral activity, and structure–activity relationships of natural 1,4-naphthoquinones and their derivatives. It highlights their potential as efficient and low-toxicity antitumor and anti-infectious drug candidates.

23 April 2019 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
YFYu Fan
Yu Fan
SXShouyan Xiang
Shouyan Xiang
ZDZhe Dai
Zhe Dai
CZChen Zou
Chen Zou
XWXiaoyan Wang
Xiaoyan Wang
ZGZhenjun Gao
Zhenjun Gao

14 March 2025 in Molecules
Verified
Journal Article
Open access
PDF file
JCJiahua Cui
Jiahua Cui
SXShouyan Xiang
Shouyan Xiang
QZQijing Zhang
Qijing Zhang
SXShangqing Xiao
Shangqing Xiao
GYGaoyang Yuan
Gaoyang Yuan
SLShaoshun Li
Shaoshun Li
We have designed, synthesized, and characterized a small library of shikonin derivatives and demonstrated their inhibitory activity against the main protease, Mpro, of SARS-CoV-2. One analog, 5,8-dimethyl shikonin oxime (15), exhibited the highest activity against SARS-CoV-2 Mpro with an IC50 value of 12.53 ± 3.59 μM. It exhibited much less toxicity as compared with the parent compound, shikonin, in both in vitro and in vivo models. Structure–activity relationship analysis indicated that the oxime moieties on the naphthalene ring and the functional groups attached to the oxygen atom on the side chain play a pivotal role in enzymatic inhibitory activity. Molecular docking results implied that the inhibitor 15 is perfectly settled in the core of the substrate-binding pocket of Mpro by possibly interacting with three catalytic residues, His41, Cys145, and Met165. Overall, the shikonin oxime derivative 15 deserves further investigation as an antiviral agent against SARS-CoV-2.

17 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
SXShouyan Xiang
Shouyan Xiang
YLYubei Li
Yubei Li
Shah Nawaz KhanShah Nawaz Khan
Shah Nawaz Khan
WZWeixin Zhang
Weixin Zhang
JCJiahua Cui
Jiahua Cui
Cancer remains a primary cause of mortality, with over 18.1 million new cases and 9.6 million deaths globally in 2018. Chemotherapy, which utilizes a spectrum of cytotoxic drugs targeting rapidly dividing cancer cells, is a predominant treatment modality. However, the tendency of chemotherapeutics to induce drug resistance and exhibit non-specific cytotoxicity necessitates the development of new anticancer agents with heightened efficacy and minimized toxicity. In recent years, the discovery of safe and effective antibacterial/antiviral agents has also been a hot spot in medicinal chemistry. This paper comprehensively reviews the synthesis, anticancer/ antibacterial/antiviral activity, and structure-activity relationships of natural 1,4-naphthoquinones and their derivatives. It highlights their potential as efficient and low-toxicity anti-tumor and anti-infectious drug candidates.